Chapman v. Procter & Gamble Distributing, LLC

Petition for certiorari denied on May 18, 2015

Docket No.	Op. Below	Argument	Opinion	Vote	Author	Term
14-958	11th Cir.	N/A	N/A	N/A	N/A	OT 2014

Issue: Whether Federal Rule of Evidence 702, as interpreted by Daubert v. Merrell Dow Pharmaceuticals and its progeny, permits a district court to require epidemiological evidence as a precondition for admissibility of a qualified expert's opinion that a toxic substance is capable of causing a particular disease.

SCOTUSblog Coverage

Petition of the day (Maureen Johnston, April 22, 2015)

Date	Proceedings and Orders (key to color coding)
11/26/2014	Application (14A563) to extend the time to file a petition for a writ of certiorari from December 10, 2014 to February 6, 2015, submitted to Justice Thomas.
12/03/2014	Application (14A563) granted by Justice Thomas extending the time to file until February 6, 2015.
02/06/2015	Petition for a writ of certiorari filed. (Response due March 11, 2015)
03/06/2015	Order extending time to file response to petition to and including April 10, 2015.
04/10/2015	Brief of respondents Procter & Gamble Distributing, LLC, et al. in opposition filed.
04/28/2015	DISTRIBUTED for Conference of May 14, 2015.
04/28/2015	Reply of petitioners Marianne Chapman and Daniel Chapman filed. (Distributed)
05/18/2015	Petition DENIED. Justice Alito took no part in the consideration or decision of this petition.